BLMN Form 4 reports acquisition/exercise transactions

Keating Colleen reported acquisition or exercise transactions in a Form 4 filing for BLMN.

Rhea-AI Filing Summary

Keating Colleen reported acquisition or exercise transactions in a Form 4 filing for BLMN. The filing lists transactions totaling 5,592 shares. Following the reported transactions, holdings were 5,592 shares.

Insider Trade Summary

Grant/Award: 5,592 shares

Grant/Award 2 txns

Insider Keating Colleen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	5,592	$0.00	$0.00
holding	No securities beneficially owned.	--	--	--

Holdings After Transaction: Restricted Stock Units — 5,592 contracts (Direct); No securities beneficially owned. — 0 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the issuer upon vesting of the unit.
2. F2. These RSUs, in the original grant amount of 5,592, will fully vest immediately prior to the issuer's annual meeting of stockholders in 2026.
3. F3. This field is not applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bloomin' Brands (BLMN) disclose for Colleen Keating?

Bloomin' Brands disclosed that director Colleen Keating received a grant of 5,592 restricted stock units on February 11, 2026. These RSUs are a form of stock-based compensation and each unit represents the right to receive one share of common stock upon vesting.

How many restricted stock units were granted to the Bloomin' Brands (BLMN) director?

Colleen Keating was granted 5,592 restricted stock units. The filing states this original grant amount and notes that each RSU converts into one share of Bloomin' Brands common stock when the vesting conditions, tied to the 2026 annual meeting, are satisfied.

When do Colleen Keating’s Bloomin' Brands (BLMN) RSUs vest?

The 5,592 restricted stock units granted to Colleen Keating will fully vest immediately prior to Bloomin' Brands’ annual meeting of stockholders in 2026. At that time, each vested RSU entitles her to receive one share of the company’s common stock.

Did the Bloomin' Brands (BLMN) director buy shares on the open market?

No, the filing shows an equity grant, not an open-market purchase. The 5,592 restricted stock units were awarded at a stated price of $0 per unit as part of director compensation, rather than being bought for cash in the market.

How many Bloomin' Brands (BLMN) securities does Colleen Keating own after this Form 4?

After the reported transaction, Colleen Keating directly holds 5,592 derivative securities in the form of restricted stock units. The non-derivative table indicates she beneficially owns zero shares of Bloomin' Brands common stock directly following this transaction.

What does each Bloomin' Brands (BLMN) restricted stock unit represent for Colleen Keating?

Each restricted stock unit represents the contingent right to receive one share of Bloomin' Brands common stock upon vesting. This means that once the vesting condition, tied to the 2026 annual meeting, is met, each RSU converts into one common share for the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 06:03 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Keating Colleen

(Last) (First) (Middle)

2202 N. WEST SHORE BLVD.

SUITE 500

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bloomin' Brands, Inc. [ BLMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
No securities beneficially owned.								0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	02/11/2026		A		5,592		(2)	(3)	Common Stock	5,592	$0	5,592	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the issuer upon vesting of the unit.

2. These RSUs, in the original grant amount of 5,592, will fully vest immediately prior to the issuer's annual meeting of stockholders in 2026.

3. This field is not applicable.

Remarks:

	/s/ Allison Hicks, Attorney in Fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.